Masimo Corp
NASDAQ:MASI

Watchlist Manager
Masimo Corp Logo
Masimo Corp
NASDAQ:MASI
Watchlist
Price: 172.96 USD 2.27% Market Closed
Market Cap: 9.3B USD
Have any thoughts about
Masimo Corp?
Write Note

Masimo Corp
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Masimo Corp
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Masimo Corp
NASDAQ:MASI
Long-Term Debt
$733.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
144%
Becton Dickinson and Co
NYSE:BDX
Long-Term Debt
$17.9B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Long-Term Debt
$9.2B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Long-Term Debt
$13.3B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
15%
Abbott Laboratories
NYSE:ABT
Long-Term Debt
$13.1B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Masimo Corp
Glance View

Market Cap
9.3B USD
Industry
Health Care

Masimo Corp. is a pioneering medical technology company that specializes in innovative non-invasive monitoring solutions. Founded in 1989 and headquartered in Irvine, California, Masimo revolutionized the field of patient monitoring with its groundbreaking pulse oximetry technology, which provides accurate blood oxygen saturation levels in a wide range of settings, from hospitals to home care. The company has continued to expand its product portfolio, introducing advanced monitoring solutions that measure multiple physiological parameters critical for patient care. With a strong emphasis on research and development, Masimo maintains a competitive edge, driving both innovation and customer loyalty across the global healthcare market. For investors, Masimo presents a compelling growth story. As the demand for effective remote patient monitoring rises, driven by trends in telehealth and an aging population, the company is well-positioned to capitalize on these opportunities. Masimo's focus on integrating sophisticated technologies, such as measure-through motion and low perfusion capabilities, sets it apart from traditional monitoring devices. Moreover, with a solid financial foundation and a history of steady revenue growth, Masimo continues to demonstrate resilience in the face of market challenges. This combination of innovation, market demand, and financial stability makes Masimo Corp. an intriguing option for investors looking to tap into the evolving landscape of healthcare technology.

MASI Intrinsic Value
128.09 USD
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Masimo Corp's Long-Term Debt?
Long-Term Debt
733.2m USD

Based on the financial report for Sep 28, 2024, Masimo Corp's Long-Term Debt amounts to 733.2m USD.

What is Masimo Corp's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
144%

Over the last year, the Long-Term Debt growth was -19%.

Back to Top